ConMed could be poised for some merger & acquisition activity as new management engineers a turnaround, according to a Wall Street analyst.
ConMed (NSDQ:CNMD), in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1JxeeQc
Cap comentari:
Publica un comentari a l'entrada